Altitude and Diving Physiology — MCQs

Q: Ascent to high altitude may cause all of the following except:

Cerebral palsy. **Explanation:** The physiological changes at high altitude are primarily driven by **hypobaric hypoxia** (low partial pressure of oxygen). **Why Cerebral Palsy is the correct answer:** Cerebral palsy is a non-progressive clinical syndrome resulting from an insult to the **developing fetal or infant brain** (typically due to birth asphyxia, infection, or trauma). It is a developmental neurological disorder and is not an acute or chronic manifestation of high-altitude exposure in adults or children. **Analysis of incorrect options:** * **Cerebral Edema (HACE):** High Altitude Cerebral Edema occurs due to hypoxia-induced cerebral vasodilation and increased capillary permeability (vasogenic edema). It is a life-threatening emergency. * **Pulmonary Edema (HAPE):** Hypoxia causes **hypoxic pulmonary vasoconstriction (HPV)**. When this is uneven or severe, it leads to increased pulmonary capillary hydrostatic pressure and leakage of fluid into the alveoli. * **Venous Thrombosis:** High altitude increases the risk of thromboembolism due to a "Virchow’s triad" effect: **Hemoconcentration** (increased hematocrit due to erythropoietin release), dehydration, and relative stasis during cold-induced inactivity. **High-Yield Clinical Pearls for NEET-PG:** * **HAPE** is the most common cause of death related to high altitude. * **Acetazolamide** (a carbonic anhydrase inhibitor) is the drug of choice for prophylaxis of Acute Mountain Sickness (AMS) as it induces metabolic acidosis, stimulating ventilation. * **Nifedipine** is used for the prevention/treatment of HAPE by reducing pulmonary artery pressure. * **Dexamethasone** is the drug of choice for HACE.

Q: Monge's disease refers to:

High Altitude Erythrocytosis. **Explanation:** **Monge’s Disease**, also known as **Chronic Mountain Sickness (CMS)**, is a condition that develops in long-term residents of high altitudes (usually above 3,000 meters). **Why the correct answer is right:** The hallmark of Monge’s disease is **High Altitude Erythrocytosis**. Due to chronic exposure to low partial pressure of oxygen ($FiO_2$), the body overproduces erythropoietin, leading to an excessive increase in red blood cell mass (hematocrit often >65%). This results in extreme blood hyperviscosity, leading to symptoms like cyanosis, fatigue, headache, and right-sided heart failure (cor pulmonale). **Why the incorrect options are wrong:** * **Primary Familial Polycythemia:** This is a genetic condition caused by mutations in the erythropoietin receptor; it is not triggered by altitude. * **Spurious Polycythemia (Gaisbock’s Syndrome):** This occurs when plasma volume decreases (e.g., dehydration or stress), making the RBC count appear high relatively, though the total RBC mass remains normal. * **Polycythemia Vera:** This is a myeloproliferative neoplasm (primary polycythemia) caused by a mutation in the **JAK2 gene**, leading to autonomous RBC production regardless of oxygen levels. **High-Yield Clinical Pearls for NEET-PG:** * **Treatment:** The definitive treatment for Monge’s disease is **descent to lower altitudes**. Periodic phlebotomy can provide symptomatic relief. * **Acetazolamide:** Often used for Acute Mountain Sickness (AMS), it works by inducing metabolic acidosis, which stimulates ventilation. * **Key Distinction:** Unlike Acute Mountain Sickness or HAPE, Monge’s disease is a **chronic** maladaptation to altitude.

Q: Which of the following is seen in high altitude climbers?

Decreased PaCO2. **Explanation:** The primary physiological challenge at high altitude is the decrease in barometric pressure, which leads to a lower partial pressure of inspired oxygen ($PiO_2$). This results in **hypoxia**. **Why B is the correct answer:** In response to hypoxia, peripheral chemoreceptors (carotid and aortic bodies) are stimulated, leading to **hyperventilation**. While hyperventilation (Option A) is a physiological *process* that occurs, the question asks what is *seen* (the biochemical result) in the climber. Increased ventilation causes excessive "washing out" of Carbon Dioxide from the lungs. This leads to **Hypocapnia** (Decreased $PaCO_2$) and subsequent respiratory alkalosis. This decrease in $PaCO_2$ is a hallmark finding in acute altitude exposure. **Analysis of Incorrect Options:** * **A. Hyperventilation:** While this occurs, it is the *mechanism* rather than the resultant laboratory/blood gas finding. In many competitive exams, if both a process and its direct chemical result are listed, the specific biochemical change ($PaCO_2$) is often the preferred answer. * **C. Pulmonary Edema:** High Altitude Pulmonary Edema (HAPE) is a pathological complication, not a universal finding in all climbers. It occurs due to uneven hypoxic pulmonary vasoconstriction. * **D. Hypertension:** Systemic hypertension is not a standard finding; however, **Pulmonary Hypertension** occurs due to hypoxic pulmonary vasoconstriction. **High-Yield Clinical Pearls for NEET-PG:** * **Oxygen Dissociation Curve:** Initially shifts to the **right** (due to increased 2,3-BPG) to favor oxygen unloading at tissues. * **Polycythemia:** Chronic exposure stimulates Erythropoietin (EPO) release from the kidneys, increasing RBC count. * **Acetazolamide:** The drug of choice for Acute Mountain Sickness (AMS); it inhibits carbonic anhydrase, causing bicarbonate diuresis and metabolic acidosis, which counteracts the respiratory alkalosis and stimulates breathing.

Q: Which of the following metabolic changes are observed in acclimatization?

Respiratory alkalosis. **Explanation:** The primary physiological challenge at high altitude is the decrease in the partial pressure of oxygen ($PO_2$), leading to **hypoxia**. **1. Why Respiratory Alkalosis is Correct:** In response to hypoxia, peripheral chemoreceptors (carotid and aortic bodies) are stimulated, leading to **hyperventilation**. This increased rate and depth of breathing "wash out" carbon dioxide ($CO_2$) from the blood. According to the Henderson-Hasselbalch equation, a decrease in $PCO_2$ (hypocapnia) raises the blood pH, resulting in **Respiratory Alkalosis**. This is the hallmark initial acid-base change in altitude acclimatization. **2. Why other options are incorrect:** * **Metabolic Alkalosis (A):** This would involve an increase in bicarbonate ($HCO_3^-$), which does not occur. In fact, the kidneys compensate for respiratory alkalosis by *excreting* bicarbonate. * **Metabolic Acidosis (B):** While the compensatory phase involves a decrease in bicarbonate (mimicking a metabolic acidosis pattern), the primary driving change is respiratory. * **Respiratory Acidosis (D):** This occurs when $CO_2$ is retained (e.g., COPD or hypoventilation), which is the opposite of what happens at altitude. **High-Yield Clinical Pearls for NEET-PG:** * **Bicarbonate Compensation:** After 24–48 hours, the kidneys increase the excretion of $HCO_3^-$ to normalize pH. This is why **Acetazolamide** (a carbonic anhydrase inhibitor) is used for prophylaxis; it forces bicarbonate excretion, creating a mild metabolic acidosis that stimulates ventilation. * **Oxygen Dissociation Curve:** Initially, alkalosis shifts the curve to the **left** (increasing $O_2$ affinity). However, with prolonged stay, 2,3-BPG levels increase, shifting the curve back to the **right** to facilitate oxygen unloading at tissues. * **Polycythemia:** Hypoxia stimulates Erythropoietin (EPO) release, leading to increased RBC production over weeks.

Q: High-altitude acclimatization may be facilitated by all of the following except?

Growth of new skeletal muscle fibers. **Explanation:** The physiological response to high altitude is centered on overcoming **hypoxia** (decreased oxygen availability). Acclimatization involves mechanisms that improve oxygen delivery and utilization at the cellular level. **Why Option D is the correct answer:** Acclimatization does **not** involve the growth of new skeletal muscle fibers (hyperplasia). In fact, prolonged exposure to high altitude often leads to a **decrease in muscle fiber diameter** (atrophy). This reduction in muscle mass is an adaptive mechanism that decreases the distance oxygen must travel from the capillaries to the mitochondria, thereby improving diffusion efficiency. **Analysis of Incorrect Options:** * **A. Increased RBC production:** Hypoxia stimulates the kidneys to release **Erythropoietin (EPO)**, which increases red blood cell production (polycythemia). This increases the oxygen-carrying capacity of the blood. * **B. Increased alveolar ventilation:** Low partial pressure of oxygen ($PO_2$) stimulates peripheral chemoreceptors, leading to hyperventilation. This helps blow off $CO_2$ and increases the alveolar $PO_2$. * **C. Growth of new blood vessels:** Chronic hypoxia triggers **Angiogenesis** (increased capillary density) in tissues, particularly in the heart and skeletal muscles, to shorten the diffusion path for oxygen. **NEET-PG High-Yield Pearls:** 1. **2,3-BPG:** Acclimatization leads to an increase in 2,3-Bisphosphoglycerate, which shifts the Oxygen-Dissociation Curve (ODC) to the **right**, facilitating oxygen unloading at the tissues. 2. **Acid-Base Balance:** Hyperventilation causes **Respiratory Alkalosis**. The kidneys compensate by increasing bicarbonate excretion (Acetazolamide can be used to speed up this process). 3. **Pulmonary Hypertension:** Hypoxia causes pulmonary vasoconstriction, which can lead to Right Ventricular Hypertrophy and High-Altitude Pulmonary Edema (HAPE).

Q: In deep sea divers, decompression illness is mainly due to which factor?

Nitrogen gas. **Explanation:** **Decompression Sickness (Caisson Disease/The Bends)** occurs due to the principles of **Henry’s Law**, which states that the solubility of a gas in a liquid is directly proportional to its partial pressure. 1. **Why Nitrogen is the correct answer:** When a diver descends, the high ambient pressure causes large amounts of **Nitrogen** (a relatively inert gas) to dissolve into the blood and tissues (especially fat). If the diver ascends too rapidly, the ambient pressure drops quickly, and the dissolved nitrogen comes out of solution faster than it can be exhaled. This leads to the formation of **nitrogen gas bubbles** in the blood and tissues. These bubbles cause mechanical obstruction (emboli), joint pain ("the bends"), and neurological symptoms. 2. **Why other options are incorrect:** * **Oxygen narcosis:** High partial pressures of oxygen can be toxic to the CNS (causing seizures), but oxygen is rapidly metabolized by tissues and does not form bubbles during ascent. * **Hypoxia:** This refers to low oxygen levels. While it can occur if gas mixtures are incorrect, it is not the mechanism behind decompression illness. * **Carbon dioxide narcosis:** CO₂ retention can cause respiratory acidosis and narcosis, but it is highly soluble and does not form the bubbles characteristic of decompression sickness. **High-Yield Clinical Pearls for NEET-PG:** * **Henry’s Law:** Governs decompression sickness. * **Haldane’s Principle:** Used to calculate decompression stages. * **Treatment:** 100% Oxygen and **Hyperbaric Oxygen Therapy (HBOT)** to re-dissolve the bubbles. * **Prevention:** Divers use **Helium-Oxygen (Heliox)** mixtures because Helium is less soluble in body tissues and has a lower molecular weight, making it easier to breathe at depth. * **Chokes:** A severe form of decompression sickness involving nitrogen bubbles in the pulmonary capillaries, leading to dyspnea and cough.

Q: Which of the following agents may be used as prophylaxis in high altitude pulmonary edema?

Nifedipine. **Explanation:** **High Altitude Pulmonary Edema (HAPE)** is a non-cardiogenic pulmonary edema caused by exaggerated **hypoxic pulmonary vasoconstriction (HPV)**. This leads to increased pulmonary capillary pressure, causing fluid leakage into the alveoli. **Why Nifedipine is correct:** Nifedipine is a **Calcium Channel Blocker (CCB)** that acts as a potent pulmonary vasodilator. By inhibiting the constriction of pulmonary arterioles, it reduces pulmonary artery pressure and prevents the hydrostatic leakage of fluid. It is the drug of choice for the **prophylaxis and treatment** of HAPE in individuals susceptible to the condition. **Analysis of Incorrect Options:** * **Acetazolamide (CAI):** While it is a Carbonic Anhydrase Inhibitor (CAI), it is the drug of choice for **Acute Mountain Sickness (AMS)** and **High Altitude Cerebral Edema (HACE)**, not specifically for HAPE prophylaxis. It works by inducing metabolic acidosis, which stimulates ventilation. * **Digoxin:** This is an inotropic agent used in heart failure and certain arrhythmias. HAPE is a non-cardiogenic condition; therefore, improving myocardial contractility with Digoxin has no role in its management. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Treatment:** The most effective treatment for all high-altitude illnesses is **immediate descent** and supplemental oxygen. * **HAPE Pathophysiology:** Characterized by patchy pulmonary edema and protein-rich exudate. * **Other Drugs:** **Tadalafil/Sildenafil** (PDE-5 inhibitors) can also be used for HAPE prophylaxis as they decrease pulmonary vascular resistance. **Dexamethasone** is primarily used for HACE and AMS. * **Gamow Bag:** A portable hyperbaric chamber used as a temporary measure when descent is not possible.

Q: Side effects of hyperbaric oxygen therapy include all of the following EXCEPT:

Increased pulmonary compliance. **Explanation:** Hyperbaric Oxygen Therapy (HBOT) involves breathing 100% oxygen at pressures greater than 1 atmosphere. While therapeutic, prolonged exposure to high partial pressures of oxygen ($PO_2$) leads to **Oxygen Toxicity** (Paul Bert and Lorrain Smith effects), primarily affecting the central nervous system and the lungs. **Why Option B is the Correct Answer:** Hyperbaric oxygen **decreases** pulmonary compliance, it does not increase it. High $PO_2$ causes oxidative stress, leading to the inactivation of pulmonary surfactant and damage to type II pneumocytes. This results in "stiff lungs," making them harder to inflate, thereby reducing compliance. **Analysis of Incorrect Options:** * **A. Absorption Atelectasis:** When breathing 100% oxygen, nitrogen (which normally keeps alveoli splinted open) is washed out. Oxygen is rapidly absorbed into the blood; if an airway is even slightly obstructed, the alveolus collapses, leading to atelectasis. * **C. Decreased Vital Capacity:** This is one of the earliest measurable signs of pulmonary oxygen toxicity. It occurs due to a combination of airway congestion, alveolar edema, and the aforementioned atelectasis. * **D. Endothelial Damage:** High levels of reactive oxygen species (ROS) directly damage the pulmonary capillary endothelium, leading to increased permeability, pulmonary edema, and eventually hyaline membrane formation. **High-Yield Clinical Pearls for NEET-PG:** * **Lorrain Smith Effect:** Refers to pulmonary oxygen toxicity (presents as substernal burning, cough, and reduced vital capacity). * **Paul Bert Effect:** Refers to CNS oxygen toxicity (presents as seizures/convulsions when $PO_2$ > 2 atm). * **Other Side Effects:** Myopia (reversible), barotrauma (middle ear squeeze), and retrolental fibroplasia (in neonates). * **Key Contraindication:** Untreated pneumothorax is an absolute contraindication for HBOT.

A 25-year-old elite swimmer training at sea level travels to compete at altitude (2400 meters). After 2 days of acclimatization, she experiences decreased performance. Her arterial blood gas shows pH 7.46, PaO2 65 mmHg, PaCO2 32 mmHg, HCO3- 22 mEq/L. Analyze the limiting factor for her current exercise performance at altitude.

Q2Easy

Ascent to high altitude may cause all of the following except:

Q3Easy

Monge's disease refers to:

Q4Medium

Which of the following is seen in high altitude climbers?

Q5Medium

Acclimatization to high altitude is associated with which of the following changes?

Q6Easy

Which of the following metabolic changes are observed in acclimatization?

Q7Medium

High-altitude acclimatization may be facilitated by all of the following except?

Q8Easy

In deep sea divers, decompression illness is mainly due to which factor?

Q9Medium

Which of the following agents may be used as prophylaxis in high altitude pulmonary edema?

Q10Easy

Side effects of hyperbaric oxygen therapy include all of the following EXCEPT:

Altitude and Diving Physiology Indian Medical PG Practice Questions and MCQs

Question 1: A 25-year-old elite swimmer training at sea level travels to compete at altitude (2400 meters). After 2 days of acclimatization, she experiences decreased performance. Her arterial blood gas shows pH 7.46, PaO2 65 mmHg, PaCO2 32 mmHg, HCO3- 22 mEq/L. Analyze the limiting factor for her current exercise performance at altitude.

A. Decreased plasma volume reducing stroke volume and cardiac output
B. Alkalosis shifting the oxygen-hemoglobin dissociation curve leftward
C. Incomplete respiratory compensation reducing oxygen delivery
D. Inadequate time for erythropoietin-stimulated red blood cell production (Correct Answer)
E. Reduced oxidative enzyme activity in skeletal muscle mitochondria

Explanation: ***Inadequate time for erythropoietin-stimulated red blood cell production*** - While **erythropoietin (EPO)** levels rise within hours of arrival at altitude, significant **polycythemia** and increased red cell mass take **2-4 weeks** to develop. - After only 2 days, the athlete has a lower **PaO2** without the increased **hemoglobin (Hb)** needed to restore total **arterial oxygen content (CaO2)**, limiting her aerobic capacity. *Decreased plasma volume reducing stroke volume and cardiac output* - **Plasma volume** does decrease shortly after reaching altitude, which can lower **stroke volume**, but this is typically a secondary factor compared to the oxygen-carrying deficit. - At 2400m, the primary limitation at submaximal exercise is the **hypoxia** rather than a failure of the **frank-starling mechanism**. *Alkalosis shifting the oxygen-hemoglobin dissociation curve leftward* - The **respiratory alkalosis** (pH 7.46) causes a **left shift**, which increases oxygen affinity in the lungs but may hinder **unloading** at tissues. - This effect is often self-limiting as levels of **2,3-BPG** rise within days to shift the curve back to the right, mitigating this as a primary performance limiter. *Incomplete respiratory compensation reducing oxygen delivery* - The ABG shows a **PaCO2 of 32 mmHg**, indicating that **hypoxic ventilatory response** and respiratory compensation are already active and functioning well. - The primary issue is not the lack of breathing effort but the low **ambient PIO2** and the time-lag for the body to produce more **oxygen carriers**. *Reduced oxidative enzyme activity in skeletal muscle mitochondria* - Changes in **oxidative enzyme activity** and mitochondrial density are slow-onset **peripheral adaptations** that occur over much longer periods of altitude training. - This factor reflects a chronic adaptation rather than an acute limiting factor for performance after only **48 hours** of exposure.

Question 2: Ascent to high altitude may cause all of the following except:

A. Cerebral edema
B. Pulmonary edema
C. Cerebral palsy (Correct Answer)
D. Venous thrombosis

Explanation: **Explanation:** The physiological changes at high altitude are primarily driven by **hypobaric hypoxia** (low partial pressure of oxygen). **Why Cerebral Palsy is the correct answer:** Cerebral palsy is a non-progressive clinical syndrome resulting from an insult to the **developing fetal or infant brain** (typically due to birth asphyxia, infection, or trauma). It is a developmental neurological disorder and is not an acute or chronic manifestation of high-altitude exposure in adults or children. **Analysis of incorrect options:** * **Cerebral Edema (HACE):** High Altitude Cerebral Edema occurs due to hypoxia-induced cerebral vasodilation and increased capillary permeability (vasogenic edema). It is a life-threatening emergency. * **Pulmonary Edema (HAPE):** Hypoxia causes **hypoxic pulmonary vasoconstriction (HPV)**. When this is uneven or severe, it leads to increased pulmonary capillary hydrostatic pressure and leakage of fluid into the alveoli. * **Venous Thrombosis:** High altitude increases the risk of thromboembolism due to a "Virchow’s triad" effect: **Hemoconcentration** (increased hematocrit due to erythropoietin release), dehydration, and relative stasis during cold-induced inactivity. **High-Yield Clinical Pearls for NEET-PG:** * **HAPE** is the most common cause of death related to high altitude. * **Acetazolamide** (a carbonic anhydrase inhibitor) is the drug of choice for prophylaxis of Acute Mountain Sickness (AMS) as it induces metabolic acidosis, stimulating ventilation. * **Nifedipine** is used for the prevention/treatment of HAPE by reducing pulmonary artery pressure. * **Dexamethasone** is the drug of choice for HACE.

Question 3: Monge's disease refers to:

A. Primary Familial Polycythemia
B. High Altitude Erythrocytosis (Correct Answer)
C. Spurious Polycythemia
D. Polycythemia Vera

Explanation: **Explanation:** **Monge’s Disease**, also known as **Chronic Mountain Sickness (CMS)**, is a condition that develops in long-term residents of high altitudes (usually above 3,000 meters). **Why the correct answer is right:** The hallmark of Monge’s disease is **High Altitude Erythrocytosis**. Due to chronic exposure to low partial pressure of oxygen ($FiO_2$), the body overproduces erythropoietin, leading to an excessive increase in red blood cell mass (hematocrit often >65%). This results in extreme blood hyperviscosity, leading to symptoms like cyanosis, fatigue, headache, and right-sided heart failure (cor pulmonale). **Why the incorrect options are wrong:** * **Primary Familial Polycythemia:** This is a genetic condition caused by mutations in the erythropoietin receptor; it is not triggered by altitude. * **Spurious Polycythemia (Gaisbock’s Syndrome):** This occurs when plasma volume decreases (e.g., dehydration or stress), making the RBC count appear high relatively, though the total RBC mass remains normal. * **Polycythemia Vera:** This is a myeloproliferative neoplasm (primary polycythemia) caused by a mutation in the **JAK2 gene**, leading to autonomous RBC production regardless of oxygen levels. **High-Yield Clinical Pearls for NEET-PG:** * **Treatment:** The definitive treatment for Monge’s disease is **descent to lower altitudes**. Periodic phlebotomy can provide symptomatic relief. * **Acetazolamide:** Often used for Acute Mountain Sickness (AMS), it works by inducing metabolic acidosis, which stimulates ventilation. * **Key Distinction:** Unlike Acute Mountain Sickness or HAPE, Monge’s disease is a **chronic** maladaptation to altitude.

Question 4: Which of the following is seen in high altitude climbers?

A. Hyperventilation
B. Decreased PaCO2 (Correct Answer)
C. Pulmonary edema
D. Hypertension

Explanation: **Explanation:** The primary physiological challenge at high altitude is the decrease in barometric pressure, which leads to a lower partial pressure of inspired oxygen ($PiO_2$). This results in **hypoxia**. **Why B is the correct answer:** In response to hypoxia, peripheral chemoreceptors (carotid and aortic bodies) are stimulated, leading to **hyperventilation**. While hyperventilation (Option A) is a physiological *process* that occurs, the question asks what is *seen* (the biochemical result) in the climber. Increased ventilation causes excessive "washing out" of Carbon Dioxide from the lungs. This leads to **Hypocapnia** (Decreased $PaCO_2$) and subsequent respiratory alkalosis. This decrease in $PaCO_2$ is a hallmark finding in acute altitude exposure. **Analysis of Incorrect Options:** * **A. Hyperventilation:** While this occurs, it is the *mechanism* rather than the resultant laboratory/blood gas finding. In many competitive exams, if both a process and its direct chemical result are listed, the specific biochemical change ($PaCO_2$) is often the preferred answer. * **C. Pulmonary Edema:** High Altitude Pulmonary Edema (HAPE) is a pathological complication, not a universal finding in all climbers. It occurs due to uneven hypoxic pulmonary vasoconstriction. * **D. Hypertension:** Systemic hypertension is not a standard finding; however, **Pulmonary Hypertension** occurs due to hypoxic pulmonary vasoconstriction. **High-Yield Clinical Pearls for NEET-PG:** * **Oxygen Dissociation Curve:** Initially shifts to the **right** (due to increased 2,3-BPG) to favor oxygen unloading at tissues. * **Polycythemia:** Chronic exposure stimulates Erythropoietin (EPO) release from the kidneys, increasing RBC count. * **Acetazolamide:** The drug of choice for Acute Mountain Sickness (AMS); it inhibits carbonic anhydrase, causing bicarbonate diuresis and metabolic acidosis, which counteracts the respiratory alkalosis and stimulates breathing.

Question 5: Acclimatization to high altitude is associated with which of the following changes?

A. Hyperventilation
B. Polycythemia
C. Oxygen dissociation curve shifts to the right (Correct Answer)
D. Decreased concentration of systemic capillaries

Explanation: ### Explanation Acclimatization to high altitude involves several physiological adjustments to compensate for the decrease in the partial pressure of inspired oxygen ($PiO_2$). **Why Option C is Correct:** At high altitudes, low oxygen levels stimulate the production of **2,3-Bisphosphoglycerate (2,3-BPG)** within red blood cells. An increase in 2,3-BPG decreases the affinity of hemoglobin for oxygen, causing the **Oxygen Dissociation Curve (ODC) to shift to the right**. This shift is beneficial because it facilitates the **unloading of oxygen** from hemoglobin into the peripheral tissues, ensuring better oxygenation despite the hypoxic environment. **Analysis of Incorrect Options:** * **A. Hyperventilation:** While hyperventilation occurs immediately upon exposure to altitude (via peripheral chemoreceptors), it is an **acute response** rather than a long-term feature of established acclimatization. Over time, the body adjusts to the resulting respiratory alkalosis. * **B. Polycythemia:** This is a classic feature of acclimatization (increased RBC count due to Erythropoietin). However, in the context of this specific question, the **rightward shift of the ODC** is often considered the hallmark metabolic adaptation for tissue delivery. *Note: In many exams, both B and C are correct; however, if forced to choose the most immediate metabolic adaptation for tissue delivery, the ODC shift is prioritized.* * **D. Decreased concentration of systemic capillaries:** This is incorrect. Acclimatization actually leads to **increased capillarity** (angiogenesis) in tissues to decrease the diffusion distance for oxygen. **High-Yield NEET-PG Pearls:** 1. **ODC Shifts:** "CADET, face Right!" (Increase in **C**O2, **A**cid/H+, **D**PG, **E**xercise, and **T**emperature shifts the curve to the right). 2. **Pulmonary Circulation:** Unlike systemic vessels, pulmonary vessels undergo **hypoxic pulmonary vasoconstriction**, which can lead to High-Altitude Pulmonary Edema (HAPE). 3. **Acid-Base:** Acclimatization results in a "compensated respiratory alkalosis" as the kidneys excrete bicarbonate to offset the CO2 lost through hyperventilation.

Question 6: Which of the following metabolic changes are observed in acclimatization?

A. Metabolic alkalosis
B. Metabolic acidosis
C. Respiratory alkalosis (Correct Answer)
D. Respiratory acidosis

Explanation: **Explanation:** The primary physiological challenge at high altitude is the decrease in the partial pressure of oxygen ($PO_2$), leading to **hypoxia**. **1. Why Respiratory Alkalosis is Correct:** In response to hypoxia, peripheral chemoreceptors (carotid and aortic bodies) are stimulated, leading to **hyperventilation**. This increased rate and depth of breathing "wash out" carbon dioxide ($CO_2$) from the blood. According to the Henderson-Hasselbalch equation, a decrease in $PCO_2$ (hypocapnia) raises the blood pH, resulting in **Respiratory Alkalosis**. This is the hallmark initial acid-base change in altitude acclimatization. **2. Why other options are incorrect:** * **Metabolic Alkalosis (A):** This would involve an increase in bicarbonate ($HCO_3^-$), which does not occur. In fact, the kidneys compensate for respiratory alkalosis by *excreting* bicarbonate. * **Metabolic Acidosis (B):** While the compensatory phase involves a decrease in bicarbonate (mimicking a metabolic acidosis pattern), the primary driving change is respiratory. * **Respiratory Acidosis (D):** This occurs when $CO_2$ is retained (e.g., COPD or hypoventilation), which is the opposite of what happens at altitude. **High-Yield Clinical Pearls for NEET-PG:** * **Bicarbonate Compensation:** After 24–48 hours, the kidneys increase the excretion of $HCO_3^-$ to normalize pH. This is why **Acetazolamide** (a carbonic anhydrase inhibitor) is used for prophylaxis; it forces bicarbonate excretion, creating a mild metabolic acidosis that stimulates ventilation. * **Oxygen Dissociation Curve:** Initially, alkalosis shifts the curve to the **left** (increasing $O_2$ affinity). However, with prolonged stay, 2,3-BPG levels increase, shifting the curve back to the **right** to facilitate oxygen unloading at tissues. * **Polycythemia:** Hypoxia stimulates Erythropoietin (EPO) release, leading to increased RBC production over weeks.

Question 7: High-altitude acclimatization may be facilitated by all of the following except?

A. Increased production of red blood cells
B. Increased alveolar ventilation
C. Growth of new blood vessels
D. Growth of new skeletal muscle fibers (Correct Answer)

Explanation: **Explanation:** The physiological response to high altitude is centered on overcoming **hypoxia** (decreased oxygen availability). Acclimatization involves mechanisms that improve oxygen delivery and utilization at the cellular level. **Why Option D is the correct answer:** Acclimatization does **not** involve the growth of new skeletal muscle fibers (hyperplasia). In fact, prolonged exposure to high altitude often leads to a **decrease in muscle fiber diameter** (atrophy). This reduction in muscle mass is an adaptive mechanism that decreases the distance oxygen must travel from the capillaries to the mitochondria, thereby improving diffusion efficiency. **Analysis of Incorrect Options:** * **A. Increased RBC production:** Hypoxia stimulates the kidneys to release **Erythropoietin (EPO)**, which increases red blood cell production (polycythemia). This increases the oxygen-carrying capacity of the blood. * **B. Increased alveolar ventilation:** Low partial pressure of oxygen ($PO_2$) stimulates peripheral chemoreceptors, leading to hyperventilation. This helps blow off $CO_2$ and increases the alveolar $PO_2$. * **C. Growth of new blood vessels:** Chronic hypoxia triggers **Angiogenesis** (increased capillary density) in tissues, particularly in the heart and skeletal muscles, to shorten the diffusion path for oxygen. **NEET-PG High-Yield Pearls:** 1. **2,3-BPG:** Acclimatization leads to an increase in 2,3-Bisphosphoglycerate, which shifts the Oxygen-Dissociation Curve (ODC) to the **right**, facilitating oxygen unloading at the tissues. 2. **Acid-Base Balance:** Hyperventilation causes **Respiratory Alkalosis**. The kidneys compensate by increasing bicarbonate excretion (Acetazolamide can be used to speed up this process). 3. **Pulmonary Hypertension:** Hypoxia causes pulmonary vasoconstriction, which can lead to Right Ventricular Hypertrophy and High-Altitude Pulmonary Edema (HAPE).

Question 8: In deep sea divers, decompression illness is mainly due to which factor?

A. Oxygen narcosis
B. Nitrogen gas (Correct Answer)
C. Hypoxia
D. Carbon dioxide narcosis

Explanation: **Explanation:** **Decompression Sickness (Caisson Disease/The Bends)** occurs due to the principles of **Henry’s Law**, which states that the solubility of a gas in a liquid is directly proportional to its partial pressure. 1. **Why Nitrogen is the correct answer:** When a diver descends, the high ambient pressure causes large amounts of **Nitrogen** (a relatively inert gas) to dissolve into the blood and tissues (especially fat). If the diver ascends too rapidly, the ambient pressure drops quickly, and the dissolved nitrogen comes out of solution faster than it can be exhaled. This leads to the formation of **nitrogen gas bubbles** in the blood and tissues. These bubbles cause mechanical obstruction (emboli), joint pain ("the bends"), and neurological symptoms. 2. **Why other options are incorrect:** * **Oxygen narcosis:** High partial pressures of oxygen can be toxic to the CNS (causing seizures), but oxygen is rapidly metabolized by tissues and does not form bubbles during ascent. * **Hypoxia:** This refers to low oxygen levels. While it can occur if gas mixtures are incorrect, it is not the mechanism behind decompression illness. * **Carbon dioxide narcosis:** CO₂ retention can cause respiratory acidosis and narcosis, but it is highly soluble and does not form the bubbles characteristic of decompression sickness. **High-Yield Clinical Pearls for NEET-PG:** * **Henry’s Law:** Governs decompression sickness. * **Haldane’s Principle:** Used to calculate decompression stages. * **Treatment:** 100% Oxygen and **Hyperbaric Oxygen Therapy (HBOT)** to re-dissolve the bubbles. * **Prevention:** Divers use **Helium-Oxygen (Heliox)** mixtures because Helium is less soluble in body tissues and has a lower molecular weight, making it easier to breathe at depth. * **Chokes:** A severe form of decompression sickness involving nitrogen bubbles in the pulmonary capillaries, leading to dyspnea and cough.

Question 9: Which of the following agents may be used as prophylaxis in high altitude pulmonary edema?

A. CAI
B. Acetazolamide
C. Nifedipine (Correct Answer)
D. Digoxin

Explanation: **Explanation:** **High Altitude Pulmonary Edema (HAPE)** is a non-cardiogenic pulmonary edema caused by exaggerated **hypoxic pulmonary vasoconstriction (HPV)**. This leads to increased pulmonary capillary pressure, causing fluid leakage into the alveoli. **Why Nifedipine is correct:** Nifedipine is a **Calcium Channel Blocker (CCB)** that acts as a potent pulmonary vasodilator. By inhibiting the constriction of pulmonary arterioles, it reduces pulmonary artery pressure and prevents the hydrostatic leakage of fluid. It is the drug of choice for the **prophylaxis and treatment** of HAPE in individuals susceptible to the condition. **Analysis of Incorrect Options:** * **Acetazolamide (CAI):** While it is a Carbonic Anhydrase Inhibitor (CAI), it is the drug of choice for **Acute Mountain Sickness (AMS)** and **High Altitude Cerebral Edema (HACE)**, not specifically for HAPE prophylaxis. It works by inducing metabolic acidosis, which stimulates ventilation. * **Digoxin:** This is an inotropic agent used in heart failure and certain arrhythmias. HAPE is a non-cardiogenic condition; therefore, improving myocardial contractility with Digoxin has no role in its management. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Treatment:** The most effective treatment for all high-altitude illnesses is **immediate descent** and supplemental oxygen. * **HAPE Pathophysiology:** Characterized by patchy pulmonary edema and protein-rich exudate. * **Other Drugs:** **Tadalafil/Sildenafil** (PDE-5 inhibitors) can also be used for HAPE prophylaxis as they decrease pulmonary vascular resistance. **Dexamethasone** is primarily used for HACE and AMS. * **Gamow Bag:** A portable hyperbaric chamber used as a temporary measure when descent is not possible.

Question 10: Side effects of hyperbaric oxygen therapy include all of the following EXCEPT:

A. Absorption atelectasis
B. Increased pulmonary compliance (Correct Answer)
C. Decreased vital capacity
D. Endothelial damage

Explanation: **Explanation:** Hyperbaric Oxygen Therapy (HBOT) involves breathing 100% oxygen at pressures greater than 1 atmosphere. While therapeutic, prolonged exposure to high partial pressures of oxygen ($PO_2$) leads to **Oxygen Toxicity** (Paul Bert and Lorrain Smith effects), primarily affecting the central nervous system and the lungs. **Why Option B is the Correct Answer:** Hyperbaric oxygen **decreases** pulmonary compliance, it does not increase it. High $PO_2$ causes oxidative stress, leading to the inactivation of pulmonary surfactant and damage to type II pneumocytes. This results in "stiff lungs," making them harder to inflate, thereby reducing compliance. **Analysis of Incorrect Options:** * **A. Absorption Atelectasis:** When breathing 100% oxygen, nitrogen (which normally keeps alveoli splinted open) is washed out. Oxygen is rapidly absorbed into the blood; if an airway is even slightly obstructed, the alveolus collapses, leading to atelectasis. * **C. Decreased Vital Capacity:** This is one of the earliest measurable signs of pulmonary oxygen toxicity. It occurs due to a combination of airway congestion, alveolar edema, and the aforementioned atelectasis. * **D. Endothelial Damage:** High levels of reactive oxygen species (ROS) directly damage the pulmonary capillary endothelium, leading to increased permeability, pulmonary edema, and eventually hyaline membrane formation. **High-Yield Clinical Pearls for NEET-PG:** * **Lorrain Smith Effect:** Refers to pulmonary oxygen toxicity (presents as substernal burning, cough, and reduced vital capacity). * **Paul Bert Effect:** Refers to CNS oxygen toxicity (presents as seizures/convulsions when $PO_2$ > 2 atm). * **Other Side Effects:** Myopia (reversible), barotrauma (middle ear squeeze), and retrolental fibroplasia (in neonates). * **Key Contraindication:** Untreated pneumothorax is an absolute contraindication for HBOT.

Practice by Chapter

Atmospheric Pressure and Gas Laws

Practice Questions

High Altitude Acclimatization

Practice Questions

Hypoxia and Oxygen Transport

Practice Questions

Altitude Illnesses

Practice Questions

Hyperbaric Environments

Practice Questions

Decompression Theory

Practice Questions

Physiology of Breath-Hold Diving

Practice Questions

Nitrogen Narcosis

Practice Questions

Oxygen Toxicity

Practice Questions

Fitness for Altitude and Diving

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free